CORONARY ARTERY BYPASS GRAFT SURGERY (CABG)
Clinical trials for CORONARY ARTERY BYPASS GRAFT SURGERY (CABG) explained in plain language.
Never miss a new study
Get alerted when new CORONARY ARTERY BYPASS GRAFT SURGERY (CABG) trials appear
Sign up with your email to follow new studies for CORONARY ARTERY BYPASS GRAFT SURGERY (CABG), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart bypass graft drug combo trial pulled before it began
Disease control TerminatedThis study planned to test whether taking two blood vessel-relaxing drugs (isosorbide mononitrate and amlodipine) for 24 weeks after coronary bypass surgery could prevent failure of the radial artery graft. The trial was withdrawn before enrolling any participants, so no data wer…
Matched conditions: CORONARY ARTERY BYPASS GRAFT SURGERY (CABG)
Phase: PHASE4 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:26 UTC
-
New wearable device could replace blood tests during surgery recovery
Knowledge-focused OngoingThis study tests a wearable device that continuously measures lactate levels in the fluid just under the skin. Researchers want to see if it matches standard blood tests in patients recovering from heart bypass or valve surgery. If it works, the device could make recovery more co…
Matched conditions: CORONARY ARTERY BYPASS GRAFT SURGERY (CABG)
Phase: NA • Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC